Akèy › Pèt tande bilatèral
Etid klinik pou Pèt tande bilatèral ap rekrite nan Etazini
9 etid pou Pèt tande bilatèral ap rekrite patisipan nan sit atravè Etazini.
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
Ap rekriteFaz 3
Tout laj · Tout sèks · Mizajou Sep 29, 2026 · NCT05821959Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss
Ap rekriteFaz 1/2
9 Months – 7 Years · Tout sèks · Mizajou Aug 27, 2026 · NCT07627971Sentence Shaping - DHH
Ap rekrite
Laj 9 a 15 · Tout sèks · Mizajou Aug 25, 2026 · NCT06860022Spatial Cues, Task Demands, and Auditory Selective Attention
Ap rekriteVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Aug 14, 2026 · NCT07765186Assessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi Pharmacies
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06864273Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT06936449Preschool Hearing Screening
Ap rekrite
Laj 2 a 6 · Tout sèks · Mizajou Feb 2, 2026 · NCT06058767Clinical Utility of Residual Hearing in the Cochlear Implant Ear
Ap rekrite
Laj 18 a 79 · Tout sèks · Mizajou Sep 12, 2025 · NCT04707885Speech Understanding and Listening Effort Benefits of Hearing Instruments
Ap rekrite
Laj 18 a 95 · Tout sèks · Mizajou Aug 11, 2025 · NCT07116135Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.